Trial Profile
Phase I/II study of cisplatin and S-1 with concurrent thoracic radiation therapy for inoperable locally advanced non-small-cell lung cancer (OLCSG 0501)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Sep 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2012 Actual end date (1 Jan 2012) added as reported by University Hospital Medical Information Network - Japan
- 26 Feb 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan
- 04 Jun 2009 Status changed from not stated to active, no longer recruiting.